Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024992 · ClinicalTrials.gov registry record · Phase 2
Enhancing Smoking Cessation for African American People Everywhere
A Phase 2 study, sponsored by University of Houston.
- Not yet
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT07024992 is a Phase 2 study that has not yet begun recruiting, run by University of Houston. The registered enrollment target is 300 participants.
The verdict
NCT07024992, a Phase 2 study, has not yet begun recruiting, sponsored by University of Houston.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.
Interventions
- BEHAVIORAL ESCAPE app + NRT
- BEHAVIORAL quiSTART app + NRT
- BEHAVIORAL Control (CTRL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07024992
The ClinicalTrials.gov registry entry for NCT07024992 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ESCAPE app + NRT is the first listed.
NCT07024992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07024992 about?
NCT07024992 is a clinical study titled "Enhancing Smoking Cessation for African American People Everywhere". The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized...
What is the current status of trial NCT07024992?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2026-06-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07024992?
The interventions under investigation include: ESCAPE app + NRT (BEHAVIORAL), quiSTART app + NRT (BEHAVIORAL), Control (CTRL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07024992?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.